共 50 条
- [43] Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria European Journal of Dermatology, 2020, 30 : 716 - 722
- [47] Unresponsiveness to Omalizumab in Chronic Spontaneous Urticaria Current Treatment Options in Allergy, 2020, 7 : 135 - 141